New patent expiration for Merck Sharp drug DUTREBISBy DrugPatentWatch – Make Better Decisions / April 3, 2024 Annual Drug Patent Expirations for DUTREBIS Dutrebis is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are two patents protecting this drug. The generic…Source